Literature DB >> 6453900

Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo.

B S Wang, E H Heacock, K H Collins, I F Hutchinson, N L Tilney, J A Mannick.   

Abstract

The purpose of the present study was the investigation of the effect of cyclosporin A (CsA) on the induction of alloreactivity in vitro and in vivo. Addition of CsA to mouse mixed lymphocyte cultures (MLC) not only inhibited lymphocyte proliferation but also prevented the generation of alloreactive cytolytic lymphocytes (CL). It was necessary to add CsA within the first 3 days of a 5-day MLC in order to achieve a significant suppressive effect. Lymphocytes, after being cultured in MLC with CsA for 4 days or longer, were incapable of being activated upon re-exposure to the same alloantigens although their responses to unrelated antigens remained intact, indicating antigen specificity of the suppression induced by CsA and its long-lasting effect. Furthermore, lymphocytes from mice treated with CsA after allosensitization failed to manifest primary cytotoxicity and could not be reactivated in a secondary MLC. Finally, CsA had no effect on those CL already generated, suggesting that CsA acts upon the induction of CL rather than the effector phase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

2.  Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage.

Authors:  N Mohagheghpour; C J Benike; G Kansas; C Bieber; E G Engleman
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

3.  Effect of cyclosporin A on lymphocyte activation by the calcium ionophore A23187.

Authors:  J E Kay; C R Benzie; A F Borghetti
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

4.  Generation of a long-lived IgE response in high and low responder strains of rat by co-administration of ricin and antigen.

Authors:  D Diaz-Sanchez; D M Kemeny
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

5.  Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.

Authors:  T L Bowlin; A L Rosenberger; B J McKown
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 6.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 7.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

8.  Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes.

Authors:  J E Kay; C R Benzie
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

9.  Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

Authors:  J C Reed; D E Sabath; R G Hoover; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis.

Authors:  M N Al-Aghbar; G J Alexander; K T Nouri-Aria; J Neuberger; A L Eddleston; R Williams
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.